Drugs that contain Methotrexate Sodium

1. List of Xatmep drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10231927 AZURITY Methotrexate composition
Jan, 2033

(9 years from now)

US11116724 AZURITY Methotrexate composition
Jan, 2033

(9 years from now)

US10610485 AZURITY Methotrexate composition
Jan, 2033

(9 years from now)

US9855215 AZURITY Methotrexate composition
Jan, 2033

(9 years from now)

US9259427 AZURITY Methotrexate composition
Jan, 2033

(9 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Apr 25, 2024

Market Authorisation Date: 25 April, 2017

Treatment: A method for treating acute lymphoblastic leukemia; Treatment of juvenile rheumatoid arthritis

Dosage: SOLUTION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic